LIMU team is the first in the world to demonstrate the possibility of using shock wave ultrasound for non-invasive treatment of human breast cancer
We usually only post news about our articles published in Q1 journals, however we believe our recent paper “Pilot experiment on non-invasive non-thermal disintegration of human mucinous breast carcinoma ex vivo using boiling histotripsy” published in the «Bulletin of Experimental Biology and Medicine» deserves special attention.
The publication is the first to successfully demonstrate the use of boiling histotripsy method for non-invasive non-thermal (i.e., mechanical) disintegration of human breast cancer tumor ex vivo (i.e., “outside the body”).
One of the advantages of the histotripsy method vs the existing treatment options for breast cancer is the ability to reliably monitor the procedure in real time using conventional ultrasound imaging.
In the near future, in order to bring boiling histotripsy towards clinical practice, optimization of protocols in laboratory experiments and further preclinical trials will be carried out.
For more details – see the text of the paper.